TAK logo

TAK SG&A Expense Growth

Latest reported-3.65%
TAK Quarterly SG&A Growth (QoQ) (0.00% → -3.65%)
High-resolution chart · PNG

TAK sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-3.6479%
3.2903%
13.5424%
-0.9121%
-13.5231%
9.3544%
0.8595%
-0.6473%
-5.3304%
6.6216%
5.7592%
1.9503%
-2.6229%
-2.8605%
5.4536%
7.4538%
3.6034%
-3.3101%
8.9934%
-3.5625%
-6.2055%
5.2748%
2.9534%
6.8601%
-20.0286%
1.5441%
11.6252%
-6.6706%
-11.377%
75.3948%
3.4547%
2.5698%
-15.5665%
7.9773%
5.0728%
3.7904%
-18.8216%
21.0551%
1.6783%
0.7099%
-17.2853%
8.1558%
6.7404%
-6.119%
-7.3796%
12.7125%
5.6751%
7.3129%
277.2331%
-73.8237%
5.6259%
-22.953%
139.2118%
-56.3264%
5.5779%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.